Mimicking Human Pathophysiology in Organ-on-Chip Devices

Ozlem Yesil-Celiktas, Shabir Hassan, Amir K. Miri, Sushila Maharjan, Rawan Al-kharboosh, Alfredo Quinones-Hinojosa, Yu Shrike Zhang

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Convergence of life sciences, engineering, and basic sciences has opened new horizons for biologically inspired innovations, and a considerable number of organ-on-a-chip platforms have been developed for mimicking physiological systems of biological organs such as the brain, heart, lung, kidney, liver, and gut. Various biophysicochemical factors can also be introduced into such organ-on-a-chip platforms to study metabolic and systemic effects spanning from drug toxicity to different pathologic manifestations. There is also a pressing need to develop better disease models for common pathologies using variations of these platforms. This can be achieved by recapitulating the unique microenvironment of a disease to investigate the cause and development of abnormal conditions as well as the structural and functional changes resulting from such a pathology. In this review, the organ-on-a-chip platforms that have been developed to model different pathologies of neurodegenerative, cardiovascular, respiratory, hepatic, and digestive systems, along with cancer are summarized. Although the field is still in its infancy, it is anticipated that developing disease model-on-a-chip platforms will likely be a valuable addition to the field of disease modeling, pathology studies, and improved drug discovery.

Original languageEnglish (US)
Article number1800109
JournalAdvanced Biosystems
Volume2
Issue number10
DOIs
StatePublished - Oct 1 2018

Fingerprint

Pathology
Equipment and Supplies
Biological organs
Digestive system
Digestive System
Biological Science Disciplines
Liver
Drug Discovery
Drug-Related Side Effects and Adverse Reactions
Respiratory System
Toxicity
Brain
Innovation
Kidney
Lung
Pharmaceutical Preparations
Neoplasms

Keywords

  • biomaterials
  • disease modeling
  • microfluidics
  • organ-on-a-chip
  • pathology

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Biomaterials
  • Biomedical Engineering

Cite this

Yesil-Celiktas, O., Hassan, S., Miri, A. K., Maharjan, S., Al-kharboosh, R., Quinones-Hinojosa, A., & Zhang, Y. S. (2018). Mimicking Human Pathophysiology in Organ-on-Chip Devices. Advanced Biosystems, 2(10), [1800109]. https://doi.org/10.1002/adbi.201800109

Mimicking Human Pathophysiology in Organ-on-Chip Devices. / Yesil-Celiktas, Ozlem; Hassan, Shabir; Miri, Amir K.; Maharjan, Sushila; Al-kharboosh, Rawan; Quinones-Hinojosa, Alfredo; Zhang, Yu Shrike.

In: Advanced Biosystems, Vol. 2, No. 10, 1800109, 01.10.2018.

Research output: Contribution to journalReview article

Yesil-Celiktas, O, Hassan, S, Miri, AK, Maharjan, S, Al-kharboosh, R, Quinones-Hinojosa, A & Zhang, YS 2018, 'Mimicking Human Pathophysiology in Organ-on-Chip Devices', Advanced Biosystems, vol. 2, no. 10, 1800109. https://doi.org/10.1002/adbi.201800109
Yesil-Celiktas O, Hassan S, Miri AK, Maharjan S, Al-kharboosh R, Quinones-Hinojosa A et al. Mimicking Human Pathophysiology in Organ-on-Chip Devices. Advanced Biosystems. 2018 Oct 1;2(10). 1800109. https://doi.org/10.1002/adbi.201800109
Yesil-Celiktas, Ozlem ; Hassan, Shabir ; Miri, Amir K. ; Maharjan, Sushila ; Al-kharboosh, Rawan ; Quinones-Hinojosa, Alfredo ; Zhang, Yu Shrike. / Mimicking Human Pathophysiology in Organ-on-Chip Devices. In: Advanced Biosystems. 2018 ; Vol. 2, No. 10.
@article{7cb3f149a5144f65bf7c6ba675f84ab9,
title = "Mimicking Human Pathophysiology in Organ-on-Chip Devices",
abstract = "Convergence of life sciences, engineering, and basic sciences has opened new horizons for biologically inspired innovations, and a considerable number of organ-on-a-chip platforms have been developed for mimicking physiological systems of biological organs such as the brain, heart, lung, kidney, liver, and gut. Various biophysicochemical factors can also be introduced into such organ-on-a-chip platforms to study metabolic and systemic effects spanning from drug toxicity to different pathologic manifestations. There is also a pressing need to develop better disease models for common pathologies using variations of these platforms. This can be achieved by recapitulating the unique microenvironment of a disease to investigate the cause and development of abnormal conditions as well as the structural and functional changes resulting from such a pathology. In this review, the organ-on-a-chip platforms that have been developed to model different pathologies of neurodegenerative, cardiovascular, respiratory, hepatic, and digestive systems, along with cancer are summarized. Although the field is still in its infancy, it is anticipated that developing disease model-on-a-chip platforms will likely be a valuable addition to the field of disease modeling, pathology studies, and improved drug discovery.",
keywords = "biomaterials, disease modeling, microfluidics, organ-on-a-chip, pathology",
author = "Ozlem Yesil-Celiktas and Shabir Hassan and Miri, {Amir K.} and Sushila Maharjan and Rawan Al-kharboosh and Alfredo Quinones-Hinojosa and Zhang, {Yu Shrike}",
year = "2018",
month = "10",
day = "1",
doi = "10.1002/adbi.201800109",
language = "English (US)",
volume = "2",
journal = "Advanced Biosystems",
issn = "2366-7478",
publisher = "Wiley-VCH Verlag",
number = "10",

}

TY - JOUR

T1 - Mimicking Human Pathophysiology in Organ-on-Chip Devices

AU - Yesil-Celiktas, Ozlem

AU - Hassan, Shabir

AU - Miri, Amir K.

AU - Maharjan, Sushila

AU - Al-kharboosh, Rawan

AU - Quinones-Hinojosa, Alfredo

AU - Zhang, Yu Shrike

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Convergence of life sciences, engineering, and basic sciences has opened new horizons for biologically inspired innovations, and a considerable number of organ-on-a-chip platforms have been developed for mimicking physiological systems of biological organs such as the brain, heart, lung, kidney, liver, and gut. Various biophysicochemical factors can also be introduced into such organ-on-a-chip platforms to study metabolic and systemic effects spanning from drug toxicity to different pathologic manifestations. There is also a pressing need to develop better disease models for common pathologies using variations of these platforms. This can be achieved by recapitulating the unique microenvironment of a disease to investigate the cause and development of abnormal conditions as well as the structural and functional changes resulting from such a pathology. In this review, the organ-on-a-chip platforms that have been developed to model different pathologies of neurodegenerative, cardiovascular, respiratory, hepatic, and digestive systems, along with cancer are summarized. Although the field is still in its infancy, it is anticipated that developing disease model-on-a-chip platforms will likely be a valuable addition to the field of disease modeling, pathology studies, and improved drug discovery.

AB - Convergence of life sciences, engineering, and basic sciences has opened new horizons for biologically inspired innovations, and a considerable number of organ-on-a-chip platforms have been developed for mimicking physiological systems of biological organs such as the brain, heart, lung, kidney, liver, and gut. Various biophysicochemical factors can also be introduced into such organ-on-a-chip platforms to study metabolic and systemic effects spanning from drug toxicity to different pathologic manifestations. There is also a pressing need to develop better disease models for common pathologies using variations of these platforms. This can be achieved by recapitulating the unique microenvironment of a disease to investigate the cause and development of abnormal conditions as well as the structural and functional changes resulting from such a pathology. In this review, the organ-on-a-chip platforms that have been developed to model different pathologies of neurodegenerative, cardiovascular, respiratory, hepatic, and digestive systems, along with cancer are summarized. Although the field is still in its infancy, it is anticipated that developing disease model-on-a-chip platforms will likely be a valuable addition to the field of disease modeling, pathology studies, and improved drug discovery.

KW - biomaterials

KW - disease modeling

KW - microfluidics

KW - organ-on-a-chip

KW - pathology

UR - http://www.scopus.com/inward/record.url?scp=85061489958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061489958&partnerID=8YFLogxK

U2 - 10.1002/adbi.201800109

DO - 10.1002/adbi.201800109

M3 - Review article

AN - SCOPUS:85061489958

VL - 2

JO - Advanced Biosystems

JF - Advanced Biosystems

SN - 2366-7478

IS - 10

M1 - 1800109

ER -